2 assets in Nondystrophic Myotonia

Therapeutic assets addressing Nondystrophic Myotonia, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Lamotrigine Nondystrophic Myotonia	Grete Andersen, MD	N/A	D (30)
Namuscla Nondystrophic Myotonia	Grete Andersen, MD	N/A	D (30)